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Abstract 
Background: Malaria remains a leading cause of morbidity and mortality in Mozambique. Increased investments 
in malaria control have reduced the burden, but few studies have estimated the costs of malaria in the country. This 
paper estimates the economic costs associated with malaria care to households and to the health system in the high 
burden district of Mopeia in central Mozambique.
Methods: Malaria care-seeking and morbidity costs were routinely collected among 1373 households with at least 
one child enrolled in an active case detection (ACD) cohort in Mopeia, and through cross-sectional surveys with 824 
families in 2017 and 805 families in 2018. Household costs included direct medical expenses, transportation and 
opportunity costs of the time lost due to illness. Structured questionnaires were used to estimate the health system 
costs associated with malaria care in all 13 district health facilities. Cost estimations followed an ingredient-based 
approach with a top-down allocation approach for health system expenses.
Results: Among participants in cross-sectional studies, households sought care for nine severe malaria cases requir-
ing hospital admission and for 679 uncomplicated malaria cases. Median household costs associated with uncompli-
cated malaria among individuals of all ages were US$ 3.46 (IQR US$ 0.07–22.41) and US$ 81.08 (IQR US$ 39.34–88.38) 
per severe case. Median household costs were lower among children under five (ACD cohort): US$ 1.63 (IQR US$ 
0.00–7.79) per uncomplicated case and US$ 64.90 (IQR US$ 49.76–80.96) per severe case. Opportunity costs were 
the main source of household costs. Median health system costs associated with malaria among patients of all ages 
were US$ 4.34 (IQR US$ 4.32–4.35) per uncomplicated case and US$ 26.56 (IQR US$ 18.03–44.09) per severe case. 
Considering household and health system costs, the overall cost of malaria care to society was US$ 7.80 per uncom-
plicated case and US$ 107.64 per severe case, representing an economic malaria burden of US$ 332,286.24 (IQR US$ 
186,355.84–1,091,212.90) per year only in Mopeia.
Conclusions: Despite the provision of free malaria services, households in Mopeia incur significant direct and indi-
rect costs associated with the disease. Furthermore, the high malaria cost on the Mozambican health system under-
scores the need to strengthen malaria prevention to reduce the high burden and improve productivity in the region.
Keywords: Malaria, Mozambique, Household costs, Health system costs, Economic burden
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/




2 ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
Full list of author information is available at the end of the article
Page 2 of 10Alonso et al. Malar J          (2019) 18:360 
Background
Malaria remains a major global health challenge, caus-
ing an estimated 435,000 deaths globally in 2017, more 
than 60% of them children under five [1]. During the last 
decade, significant reductions in malaria morbidity and 
mortality have been achieved through increased funding 
for malaria control and elimination, among other rea-
sons, which supported the scale-up of malaria prevention 
tools, such as insecticide-treated nets, and of case man-
agement, with rapid diagnostic tests (RDTs) and arte-
misinin-based combination therapy (ACT) [2].
Malaria is one of the main public health issues in 
Mozambique with an estimated 8.9 million cases and 
14,700 deaths in 2017 [1], with children under five and 
pregnant women the most at risk groups. Zambézia 
province in central Mozambique is a high transmission 
area of malaria with an RDT-based prevalence of 68% in 
children under five in 2015 [3], and up to 47.8% in chil-
dren below 15  years [4]. The peak transmission occurs 
during the rainy season (December to April), when the 
primary malaria vector species proliferate: Anopheles 
gambiae and Anopheles funestus [5]. Most of the cases 
are caused by Plasmodium falciparum infection [3], 
which may cause complications such as anemia, or cer-
ebral malaria, particularly in children under five [6], in 
whom the majority of malaria deaths are concentrated 
[1].
In Mozambique, malaria is the leading cause of care-
seeking, accounting for 45% of outpatient consulta-
tions and 24% of hospital admissions in 2015 [7]. The 
Mozambican Ministry of Health provides free diagnosis 
and treatment services for malaria at public health facili-
ties [8], but these services require considerable human 
resource and health systems investment. Scarcity of 
resources and weak health system financing force the 
country to rely on international donors for the provi-
sion of RDTs and anti-malarial medicines, the majority of 
which are purchased by the US President’s Malaria Initia-
tive and the Global Fund to Fight AIDS, Tuberculosis and 
Malaria.
Despite a policy of free universal access to malaria care 
in public facilities, patients still face several barriers, 
including limited access to malaria prevention and treat-
ment [3], and sub-optimal malaria case management [9], 
because of few and distant health facilities with limited 
health services [10, 11]. Additionally, the poorest may 
suffer more from high indirect costs, such as transpor-
tation costs and long waiting times. They may also incur 
catastrophic payments when referred to the private or 
informal sector for treatment, due to recurrent stock-
outs at public health facilities [11, 12].
The economic burden of malaria affects households, 
health systems and economic development and growth 
[13, 14]. Obtaining evidence on its economic burden 
has an important role in the economic evaluation of 
malaria control interventions and for the improved 
allocation of resources [15]. However, only a few stud-
ies have quantified the cost of malaria to families and 
the health system in Mozambique, and these have been 
conducted in the lower burden southern regions and 
in the context of evaluations of specific malaria inter-
ventions, such as intermittent prevention in infants or 
pregnant women [12, 16, 17]. No published studies are 
available on the cost of malaria in high burden areas in 
central or northern regions of Mozambique.
The objective of the present study is to determine 
the economic cost associated with malaria care on 
households, the health system, and society in the high 
malaria transmission district of Mopeia, Mozambique.
Methods
This study was part of a larger project consisting of a 
cluster randomized-control trial (RCT) to determine 
the effectiveness and cost-effectiveness of implement-
ing indoor residual spraying (IRS) with micro-encapsu-
lated pirimiphos-methyl  in an area with high coverage 
of long-lasting insecticidal bed nets (LLINs), as com-
pared to LLIN coverage alone [5]. IRS was randomly 
assigned to 43 of 86 selected villages to receive free IRS 
with Actellic 300 CS (intervention arm) before the high 
malaria season in 2017 and 2018, while villages in the 
other clusters did not receive IRS (control arm). Ran-
domization was stratified by cluster size and sampling 
utilized a ‘fried egg’ design [5]. Households in the inter-
vention and control arms had been provided with free 
standard pyrethroid LLINs through mass distribution 
campaigns and continuous distribution. At baseline, 
61–63% of households reported owning at least one 
LLIN and this increased to nearly all households follow-
ing a universal coverage campaign of standard LLINs in 
2017. Additional file  1 summarizes data sources used 
in the study and a cost categorization from which out-
come variables are extracted.
Study setting
The RCT was conducted in Mopeia district, one of 22 
districts located in the Zambézia province of central 
Mozambique. At study baseline, Mopeia consisted of 
two administrative posts, eight localities, 104 villages 
and approximately 30,000 households [18]. The district 
projected population in 2014 was 151,570 individuals 
with 23,889 children under five  years [18]. Mopeia has 
one health facility considered the district hospital and 12 
clinics.
Page 3 of 10Alonso et al. Malar J          (2019) 18:360 
Households’ costs estimation
Household costs of a clinical malaria case were deter-
mined through structured questionnaires among chil-
dren during monthly visits in an active case detection 
(ACD) cohort and among individuals of all ages in 
cross-sectional studies. Sample sizes and power con-
siderations for the ACD cohort, cross-sectional studies, 
and passive case detection (PCD) are reported else-
where [5]. A total of 1536 children aged six months to 
five years old at baseline from 1373 households partici-
pated in an ACD cohort from January 2017 to October 
2018. Trained fieldworkers conducted monthly ACD 
household visits that included malaria testing with an 
RDT and completion of structured questionnaires. 
They collected information on the household resources 
used for malaria care-seeking in order to determine the 
average household cost of an uncomplicated and severe 
malaria case for cohort children. Households were also 
asked how much time was lost to productive activities 
such as formal employment, farming, and childcare. 
Additionally, two cross-sectional studies undertook in 
May 2017 and April 2018 retrieved information on the 
resources used for malaria care-seeking among individ-
uals of all ages using the same malaria cost questions 
as the ACD, but with reference to the entire household. 
Questionnaires were developed based on previous 
studies from the literature [19, 20].
Direct costs of malaria care-seeking from formal and 
informal services were collected and consisted of medi-
cal care—treatments, diagnostic tests, consultation 
fees—and non-medical care, such as travel and other 
costs (food and telephone expenses). While malaria 
care is provided for free in public facilities in Mozam-
bique, households seek care at diverse settings. Costs 
included care from public health services (community 
health workers (CHWs) or health facilities), as well as 
informal care: traditional healers and self-treatment. 
Household costs are presented as aggregated costs 
under those categories as most of the households did 
not report costs related to consultation fees or malaria-
related test and treatment costs. Indirect costs asso-
ciated with malaria followed a wage-based valuation 
approach [21], consisting of computing the opportunity 
cost of the time loss for productive activities due to ill-
ness or caregiving. Such costs included missed work, 
agricultural activities, housework and school attend-
ance. Productive time lost was measured in hours 
and multiplied by the corresponding Mozambican 
minimum wage according to the sector of employ-
ment [22, 23]. Severe malaria was defined as any case 
requiring hospital admission. The remaining malaria 
cases not requiring hospitalization were considered 
uncomplicated.
Health system costs estimation
Provider costs associated with malaria care delivery 
were estimated through collecting information on clini-
cal resources used during malaria outpatient visits and 
hospital admissions in the district health facilities. For 
uncomplicated malaria, a structured questionnaire 
was implemented in each of the 13 health facilities in 
July 2018. It retrieved information on the health facility 
characteristics, provision of health services, as well as 
resources used during a typical outpatient visit, including 
the health worker time devoted to patient care. The cost 
of screening suspected cases was also considered [20]: 
according to the RDT positivity rate of 50% obtained in 
the PCD; for each confirmed malaria case it was assumed 
another RDT was performed that was negative [1, 5]. 
For severe malaria, trained fieldworkers used a struc-
tured questionnaire to retrospectively collect data on the 
resources used for the management of malaria admis-
sions from clinical files in the district hospital in 2016. 
These were the most recent data available at the time of 
data abstraction. Inclusion criteria for malaria admis-
sions consisted of: (1) malaria as the primary admission 
cause, (2) evidence in the clinical file of a positive para-
site-based diagnosis by RDT or microscopy, and (3) avail-
ability of the clinical file. Data were complemented with 
field interviews with health and administrative workers at 
the district level, to account for the resources used that 
were not documented in patient files, such as the alloca-
tion of overhead.
Economic costs to the health system followed an 
ingredient-based approach [24] in which all resources 
employed for the management of a malaria case were 
quantified, including all indirect costs related to those 
actions. Hence, for each input, outputs were computed 
as unit price (p) by the quantity employed (q). Economic 
costs consisted of the financial costs of resources paid by 
the Mozambican Ministry of Health and other resources 
provided by international donors, such as RDT or anti-
malarial medicines.
The average economic cost of an uncomplicated 
malaria case was computed as the mean cost of the 
resources used to manage a malaria outpatient in each 
of the district health facilities. The average economic 
cost of a severe malaria case was computed as the mean 
cost of admitted cases retrieved from the district hospital 
in 2016. For each admission, data on medical examina-
tions, diagnostic tests and treatment dosages employed 
were collected from files. Admission was based on find-
ings from laboratory and clinical examinations. Malaria 
diagnosis cost was computed as the unit price of the RDT 
and microscopy [25, 26] multiplied by the number of 
tests recorded on the patient file. In accordance with the 
national guidelines microscopy was assumed to be used 
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to check for parasitological density each day during the 
admission. Malaria treatment was computed as the price 
per dose according to patient’s age, used as a proxy for 
weight [27–29]. A three-day course artemether–lume-
fantrine (AL) was assumed to follow parenteral therapy 
with artesunate [28]. The value of health worker’s time 
was added for both malaria diagnosis and treatment, as 
well as other non-malaria related tests. Diagnostic tests 
and treatments unitary costs were retrieved from official 
prices at the district hospital, including malaria com-
modities, whose unitary prices were similar to the value 
of those commodities purchased by international donors. 
Costs on salaries, overheads and other district health sys-
tem expenditures were collected directly from the hos-
pital administration. Prices not available from Mopeia’s 
District Directorate of Health, such as blood transfusion 
costs, were obtained by a literature search or interna-
tional prices databases [30–32]. A 100% freight mark-up 
was applied to all commodities.
Health system costs included the allocation of 
Mopeia health system expenditures following a top-
down allocation approach in which annual expenses 
in 2016 were distributed according to the proportion 
of the total number of malaria outpatients and admis-
sions in relation to all-cause outpatients and admis-
sions [33]. District overhead resources consisted of the 
cost of administrative personnel salaries and benefits, 
office supplies, district official transportation and per 
diems, utilities and other goods. Utility costs included 
energy and water supply, waste management, clean-
ing or security costs at health facilities and the dis-
trict office. According to Mopeia’s District Directorate 
of Health (personal communication), the inflation-
adjusted annual budget attributable to overheads was 
US$ 175,354 in 2016. The amount was imputed to a 
cost per uncomplicated malaria case according to the 
proportion of malaria cases registered in the district 
in 2016 (39,758) among all outpatient consultations 
(170,121). For severe malaria, the inpatient utilization 
rate of malaria over the total number of cases (206/780) 
was applied to the district annual budget. That amount 
was further divided by the number of malaria admis-
sions (206) to account for the overhead costs associ-
ated to a malaria admission. Finally, it was divided by 
365 to obtain the daily hospitalization cost per malaria 
admission (US$ 0.62), which was later multiplied by the 
number of admission days for each patient to obtain the 
median hospitalization cost per malaria admission [34].
Economic burden of malaria
The value of resources associated with malaria was 
assessed following a societal perspective, which included 
the resources used by the healthcare provider and 
households, as well as the opportunity cost due to ill-
ness or caregiving [35, 36]. Thus, the societal mean and 
median cost associated with malaria was computed as the 
sum of household costs per case plus health system costs 
per case. The societal cost of uncomplicated and severe 
malaria was calculated separately for children under five 
and for all ages. The total economic burden of uncom-
plicated and severe malaria among households and the 
health system in the district was further estimated by 
multiplying the registered number of malaria cases in 
Mopeia in 2016 by the median societal costs.
Statistical analysis
Stata v15 (Statacorp) was used for data analysis. The time 
horizon for the average cost associated with uncom-
plicated and severe malaria was the complete episode 
duration for which care was provided under the house-
hold and health system perspectives. Costs were initially 
retrieved in Mozambican meticais, inflation adjusted and 
later converted to 2018 US dollars (US$). The exchange 
rates used were 63.03 metical/US$ in 2016 and 63.53 
metical/US$ in 2017 [37]. Costs were adjusted by apply-
ing the inflation rates of 12.3% in 2016 and 9.8% in 2017 
[38].
The median and the interquartile-range (IQR), in 
addition to the mean values in tables, are reported for 
households and health system costs to provide a deeper 
understanding of cost estimates, due to the typical 
skewed distribution of cost data. Mann–Whitney-Wil-
coxon test was used to identify statistically significant 
differences in the mean health system cost between: (1) 
gender; (2) children under and above five  years of age 
admitted due to malaria; and (3) admissions depend-
ing on malaria season: rainy season being from October 
to June [4]. Sample power of cited non-parametric tests 
were calculated using bootstrap simulation with 1000 
replications [15, 39].
Uncertainty was handled carrying out a univariate 
sensitivity analysis to assess the robustness of results by 
changing values of key parameters: increasing/decreas-
ing 50% the (1) price of malaria treatment (AL and 
artesunate), (2) price of RDT and (3) overhead expenses; 
increasing/decreasing 30% the (1) Mozambican mini-
mum wage and (2) health worker wage at the health facil-
ities; as well as considering no cost of screening fever.
Results
Health system characteristics
As shown in Additional file  2, most of the 13 health 
facilities in the district had catchment areas of 5001–
10,000 inhabitants. Only the district hospital had more 
than ten beds, including maternity services, but three 
health facilities had laboratories to collect and process 
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samples. One car and one motorbike were fully opera-
tional in the district hospital, while a car was also avail-
able in one other facility. The remaining facilities had 
access to these district vehicles or others lent by NGOs 
or governmental institutions.
Health providers in Mozambique include medical 
doctors, medical technicians, medical assistants and 
nurses; as well as pharmacists and laboratory tech-
nicians. However, human resources in the district 
health facilities were scarce. Only one medical doc-
tor was present in Mopeia. There were also six medi-
cal technicians, each one in a different health facility. 
Preventive medicine technicians (9/13) and medi-
cal assistants (7/13) were present in most of facilities, 
but few pharmacists (4/13) and laboratory technicians 
(3/13) worked in the facilities. Nurses were available in 
all health facilities. A total of 22 CHWs complemented 
the work of health professionals at the district facili-
ties. Their malaria-related activities consisted mainly of 
testing and treating patients at the community level.
Regarding malaria commodities, all health facilities 
had RDTs in stock at the moment of the interview but 
three out of 13 health facilities reported that stock-outs 
occurred during the last three months. However, at the 
time of data collection AL stock-outs were common for 
different formulation packages: AL 20 mg/120 mg (total 
course of six tablets) and AL 20  mg/120  mg (18 tab-
lets) were out-of-stock in three health facilities and AL 
20  mg/120  mg (12 tablets) and AL 20  mg/120  mg (24 
tablets) in two. At least one formulation of AL was out-
of-stock during the last three months in ten facilities 
(Additional file 2). Common practice in Mozambique is 
to cut or combine packaging at the facility level when a 
formulation is stocked out to provide patients with the 
correct dosage.
Household costs associated with malaria
Table  1 shows the costs of malaria care-seeking from 
the cross-sectional study population, which included all 
ages. A total of 818 households in 2017 and 801 in 2018 
reported nine severe malaria cases and 679 uncompli-
cated malaria cases, all non-fatal, of which 514 (76%) 
sought treatment at a health facility or another source 
of care, such as traditional healer or CHW. Few house-
holds reported non-zero costs at the traditional healer 
(n = 11: median = US$ 2.52, IQR = US$ 1.73–6.04), or at 
the CHW (n = 54: median = US$  0.07, IQR = US$  0.03–
0.16). Most of the households reported no costs (469 
out of 679) or less than US$ 1 (675 out of 679) concern-
ing treatment costs purchased at private or public pro-
viders. When aggregating all cost sources, the median 
household cost was US$ 3.46 (IQR US$ 0.07–22.41) per 
uncomplicated malaria case, while the median household 
cost was US$ 81.08 (IQR US$ 39.34–88.38) per severe 
malaria case. The mean costs were considerably higher 
due to some outliers who had much higher indirect costs. 
Indirect costs were the most important source of costs 
among households, representing most of the cost burden.
Additionally, a cohort of 1536 children in 1373 house-
holds was followed monthly from January 2017 to Octo-
ber 2018. As shown in Table  2, caregivers reported 
care-seeking costs associated with malaria in a child 
under five for a total of 2519 malaria cases, of which 
1224 (49%) sought care at a health facility. This lower 
care-seeking behavior was likely influenced by the treat-
ment received by study participants during ACD vis-
its. The median household cost was US$ 1.63 (IQR US$ 
Table 1 Household cost per malaria case among individuals of all ages (2018 US$)
Data from cross-sectional studies
The value of the direct costs of care-seeking is calculated as the summation of the costs related to the traditional healer, CHW, travel to/from the health facility and 
treatments after a health facility visit
CHW community health worker, IQR interquartile-range, SD standard deviation
Uncomplicated malaria care-seeking costs 
(n = 679) including outpatient consultations 
(n = 514)
Severe malaria care-seeking costs (n = 9)
Mean SD Median IQR Mean SD Median IQR
Traditional healer (including transportation) 0.29 5.29 0.00 0.00–0.00 0.00 0.00 0.00 0.00–0.00
CHW costs 0.01 0.09 0.00 0.00–0.00 0.00 0.00 0.00 0.00–0.00
Travel costs to/from the health facility 0.34 1.21 0.00 0.00–0.00 1.16 2.23 0.00 0.00–0.69
Direct costs at the health facility 0.05 0.10 0.03 0.00–0.06 2.16 2.22 2.19 0.09–3.57
Treatment costs after health facility visit 0.04 0.15 0.00 0.00–0.03 0.23 0.36 0.06 0.00–0.16
Subtotal: direct costs of care-seeking 0.74 5.47 0.05 0.00–0.19 3.54 2.93 3.75 0.60–6.31
Value of time lost in the main economic activity 16.67 31.17 2.29 0.00–22.38 154.30 192.89 76.97 31.45–87.71
Total costs 17.41 31.69 3.46 0.07–22.41 157.85 194.43 81.08 39.34–88.38
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0.00–7.79) per uncomplicated malaria case. These costs 
were mainly due to indirect costs (US$ 0.33) rather than 
direct cost of care-seeking (US$ 0.01). Additionally, ten 
households reported costs associated with severe malaria 
at the district hospital, which required hospitalization. 
The median household cost was US$ 64.90 (IQR US$ 
49.76–80.96) per severe malaria case. These costs were 
greatly explained by indirect costs (US$ 59.37) as median 
direct costs of care-seeking were US$ 2.90 per severe 
malaria case. For both, ACD and cross-sectional cohort, 
agriculture and housework were by far the main sectors 
of activity. Average median costs were sensitive to vari-
ations in minimum wages; in particular an increase of 
minimum wages in 30% would increase the household 
cost per uncomplicated malaria case by 18% and per 
severe malaria case by 10% (Additional file 3).
Health system costs associated with malaria
Clinical practices for the management of uncomplicated 
malaria were similar in all district health facilities and 
severe cases were transferred to the district hospital for 
admission. Outpatient consultations for uncomplicated 
malaria in all 13 health facilities were diagnosed through 
RDTs and prescribed AL, in accordance with national 
guidelines [1, 40]. The average health system cost was 
US$ 4.34 (IQR US$ 4.32–4.35) per uncomplicated 
malaria case, mostly due to costs related to malaria diag-
nosis (39%), which incorporated the extra cost of screen-
ing fever, and treatment (36%) (Table  3). Allocation of 
overhead reached a median cost of US$ 1.03 per uncom-
plicated malaria case [34].
Data from 107 malaria admissions were retrieved for 
the year 2016; almost half of them were children under 
five (52) and females (51) (Additional file  4). Malaria 
diagnosis and monitoring included microscopy in 72% 
of cases and RDTs in 67% of them. The vast majority 
of patients were treated with artesunate (84%) and, 
to a lesser extent, quinine (15%). Patients required a 
median of five days of hospitalization, most cases were 
discharged successfully (81%) but 10% died during hos-
pitalization. As shown in Table 4, the median cost per 
severe malaria case was US$ 26.56 (mean = US$ 36.97). 
Medical examinations, diagnostics and treatments and 
provider costs increased the cost due to the days spent 
hospitalized. The daily hospitalization cost was US$ 
0.62, which lead to a median hospitalization cost of US$ 
3.80 (IQR US$ 2.28–12.15) per malaria admission. As 
Table 2 Household cost per malaria case among children under the five (2018 US$)
Data from active case detection (ACD) surveillance system
The value of the direct costs of care-seeking is calculated as the summation of the costs related to the traditional healer, CHW, travel to/from the health facility and 
treatments after a health facility visit
CHW community health worker, IQR interquartile-range, SD standard deviation
Uncomplicated malaria care-seeking costs 
(n = 2519) including outpatient consultations 
(n = 1224)
Severe malaria care-seeking costs (n = 10)
Mean SD Median IQR Mean SD Median IQR
Traditional healer (including transportation) 0.14 1.53 0.00 0.00–0.00 0.00 0.00 0.00 0.00–0.00
CHW costs 0.01 4.27 0.00 0.00–0.00 0.00 0.00 0.00 0.00–0.00
Travel costs to/from the health facility 0.72 1.32 0.00 0.00–0.94 0.95 1.24 0.41 0.00–1.38
Direct costs at the health facility 0.03 0.16 0.00 0.00–0.02 2.98 2.53 1.85 1.21–5.50
Treatment costs after health facility visit 0.02 0.11 0.00 0.00–0.00 0.75 2.22 0.08 0.00–0.09
Subtotal: direct costs of care-seeking 0.92 4.48 0.01 0.00–1.05 4.68 4.36 2.90 1.99–6.31
Value of time lost in main economic activity for 
the primary caregiver
7.23 17.17 0.33 0.00–5.90 61.23 31.45 59.37 47.17–71.60
Total costs 8.15 18.22 1.63 0.00–7.79 65.91 32.05 64.90 49.76–80.96
Table 3 Health system costs per  uncomplicated malaria 
case among patients of all ages (2018 US$)
N = 13
IQR interquartile-range, SD standard deviation
Cost category Mean SD % of total (%) Median IQR
Medical examina-
tions
0.06 0.52 1.38 0.05 0.03–0.10
Malaria diagnostic 
tests
1.67 0.09 38.48 1.66 1.60–1.74
Malaria treatment 1.57 0.69 36.18 1.54 1.51–1.64
Overhead cost 
allocation
1.03 – 23.18 1.03 –
Total costs 4.34 0.09 4.34 4.32–4.35
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shown in Additional file 3, univariate price variations in 
malaria commodities or overhead expenditures would 
increase up to 18% the health system cost per uncom-
plicated malaria case, but would have limited impact 
on the cost per severe malaria case. No differences in 
severe malaria costs were found between sex groups, 
but costs due to severe malaria were statistically sig-
nificantly higher in children under five and in patients 
admitted during the dry season (Additional file 5).
Economic burden of malaria
As shown in Table  5, mean societal costs of malaria 
were US$ 21.75 per uncomplicated case and US$ 194.82 
per severe case among patients of all ages. Costs were 
lower for children under five. Considering these costs 
and the registered number of malaria case in Mopeia in 
2016 (39,758 outpatients and 206 admissions), the total 
economic burden of malaria in the district reached 
a median of US$ 332,286.24 (IQR US$ 186,355.84–
US$ 1,091,212.90), mainly due to uncomplicated 
(median of US$ 310,112.40, IQR US$ 174,537.62–US$ 
1,063,924.08) rather than severe malaria (median of 
US$ 22,173.84, IQR US$ 11,818.22–US$ 27,288.82).
Discussion
Understanding the household, health system and soci-
etal economic burden of malaria is essential to inform-
ing policy decisions and evaluating new interventions 
to support malaria control and elimination. This kind 
of information is particularly relevant in regions like 
Mopeia, where malaria transmission is higher and 
poorer individuals are the most at risk to the disease [3, 
41].
This study estimates the economic burden of malaria 
to households, the health system and society in a high 
transmission setting in which malaria services are pro-
vided free of charge at public health facilities. Given the 
rural and poor context of Mopeia [18], household costs 
associated with malaria care may constitute a significant 
drain on limited financial resources among the popula-
tion as the incidence of poverty reached 60% of Zam-
bézia population in 2014 [42]. A 2015 study reported a 
mean monthly expenditure per capita of 809 meticais 
in the province of Zambézia (approximately US$ 16.85) 
[43]. Hence, the median household cost associated with 
uncomplicated malaria represents between 10% (US$ 
1.63) and 21% (US$ 3.46) of the monthly expenditure 
of a family in Zambézia, while the cost of a severe case 
(US$ 64.90 and US$ 81.08) exceeds the mean monthly 
expenditure per capita by more than three times. These 
amounts might be considered catastrophic expenditures, 
considering the threshold of 10% of total expenditure on 
healthcare, especially if more than one family member 
is infected with malaria [44]. As such, malaria is likely a 
driver of a vicious cycle of poverty in this high burden 
setting [45].
The median health system cost associated with malaria 
in Mopeia district was US$ 4.34/uncomplicated and US$ 
26.56/severe malaria case. Despite obtaining slightly 
higher uncomplicated malaria costs, estimations are in 
line with those reported in a systematic review by White 
et al. in 2011 [46]; as well as those reported in Tanzania, 
Kenya and Ghana; ranging from US$ 1.75–2.89/uncom-
plicated malaria case [19]. However, estimations were 
higher in Nigeria (US$ 30.42–31.49/uncomplicated and 
US$ 48.02/severe case) [47, 48], Burkina Faso (US$ 6.74/
uncomplicated and US$ 74.29/severe case) [49], and 
Kenya (US$ 95.58/severe case) [50]. These discrepancies 
may be driven by country-specific characteristics of the 
health system, such as higher budget for hospital activi-
ties, laboratory and pediatric wards funding [48, 49], or 
the quality of care or number of tests received during the 
Table 4 Health system costs per  severe malaria case 
among patients of all ages (2018 US$)
N = 107
IQR interquartile-range, SD standard deviation
a Hospitalization costs were computed as the overhead costs allocated to an 
admission day due to malaria multiplied by the number of hospitalization days
Cost category Mean SD Median IQR
Medical examinations 3.44 0.59 3.28 3.09–3.57
Health facility transfer 4.24 22.44 0.00 0.00–0.00
Malaria diagnostic tests 8.51 3.94 7.85 5.40–12.17
Non-malaria related tests 0.52 5.27 0.00 0.00–0.00
Malaria treatment 5.00 9.41 2.42 1.56–6.32
Non-malaria related treatments 4.50 3.81 3.60 1.15–7.17
Hospitalization costs due to 
malaria  admissiona
10.75 25.84 3.80 2.28–12.15
Total costs 36.97 38.87 26.56 18.03–44.09
Table 5 Mean, median and  interquartile rage (IQR) 
societal costs associated with  a  malaria case by  age 
and disease severity (2018 US$)
Severity Mean Median IQR
Individuals of all ages
 Uncomplicated malaria 21.75 7.80 4.39–26.76
 Severe malaria 194.82 107.64 57.37–132.47
Children under five
 Uncomplicated malaria 12.49 5.97 4.32–12.14
 Severe malaria 102.88 91.46 67.79–125.05
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admission [20, 48], underscoring the relevance of having 
local data to guide cost-effectiveness analyses.
This study described the contribution of each type of 
cost to the overall economic burden of malaria. Among 
direct costs, medical costs were higher during admissions 
due to the additional medical interventions received. 
Medical costs increased with age due to the higher dos-
age required. This translated into higher costs for the use 
of antimalarial medicines among adults, which has previ-
ously been reported [51]. As expected, households’ indi-
rect costs were higher in the cross-sectional studies (all 
ages) compared to the ACD cohort (children under five) 
due to the fact that older individuals reported higher 
opportunity costs. Household care-seeking costs obtained 
in Mopeia are similar to the ones presented from other 
studies in sub-Saharan Africa. Sicuri et  al. estimated the 
average cost of uncomplicated malaria ranging from US$ 
3.56/case in Tanzania to US$ 8.68/case in Kenya, while for 
severe malaria ranged lower from US$ 19.82/hospitaliza-
tion in Tanzania to US$ 48.73/hospitalization in Ghana 
[19]. Indirect costs were also the main source of costs to 
households. Similar findings were obtained in Nigeria 
(US$ 12.57/outpatient and US$ 23.20/admission) [47] and 
Malawi (US$ 17.48/admission) [52].
All health facilities in Mopeia followed similar prac-
tices for the management of uncomplicated malaria. 
Thus, most of the variability obtained for the estimation 
of an uncomplicated malaria case was due to differences 
in salaries of the health worker examining the patient. 
Conversely, the cost associated with severe malaria 
highly depended on the disease severity, which affected 
the length of stay and number of examinations under-
taken by the health worker (both representing almost 
half of the total cost). Moreover, inter-hospital transfers, 
particularly those transferred to the provincial capital 
of Quelimane, represented up to 10% of the mean cost 
per severe malaria case even though only 8% of cases 
were transferred. Inter-hospital transfers, albeit expen-
sive, remain cheaper than expanding the management of 
severe malaria to lower level hospitals, but transfer health 
risks and costs to patients [53, 54].
The mean economic burden of malaria to society 
reached US$ 21.75/uncomplicated and US$ 194.82/
severe malaria case in patients of all ages, respectively, 
representing approximately 5% and 47% of the Mozam-
bican average annual income of US$ 415 per capita in 
2017 [55]. However, Zambézia is among the poorest 
regions in the country, with some estimates pointing to 
an average annual income of US$ 254 in 2012 [56]. Thus, 
these costs provide evidence on the high economic bur-
den of malaria to households and the health system in 
high transmission regions, such as Mopeia, and highlight 
the importance of malaria prevention to reduce the high 
morbidity and mortality rates and improve overall pro-
ductivity of the region [57].
Several limitations are associated with this study. First, 
self-reported household cost data were retrieved through 
cross-sectional and ACD studies and not through exit 
surveys at health facilities. Thus, recall bias and the 
context of the study may have influenced the responses 
regarding the actual resources spent during a malaria 
case [58]. Second, the assumption that AL was prescribed 
for all patients attending a health facility might involve 
double-counting treatment costs. However, double-
counting bias has a limited impact over total costs: 70% 
of cases in the cross-sectional cohort and 80% of them in 
the ACD cohort reported no treatment costs, and most 
of those reporting costs were lower than US$ 1. On the 
contrary, the economic cost associated with malaria is 
likely to be underestimated as certain costs were disre-
garded: costs of mortality and of other disease mani-
festations, such as anemia, or other long-term sequelae 
such as residual disability from severe malaria. Similarly, 
household care-seeking costs might be higher than the 
ones obtained here: study participants received anti-
malarial treatment when they had a positive test result, 
reducing their need for care-seeking: only 49% of malaria 
cases sought care at a health facility in the ACD cohort. 
Additionally, few households reported costs at the tra-
ditional healer (0.75% and 1.62% of ACD and cross-sec-
tional cohort, respectively) or CHW (5% and 8% of ACD 
and cross-sectional cohort, respectively), thus limiting 
a disaggregated analysis by healthcare provider. Finally, 
these results cannot be generalized to other settings or 
countries. However, generalization was not a target of the 
present study, whose main purpose was to quantify the 
economic burden of malaria for the economic evaluation 
of malaria prevention intervention(s) carried out in the 
district.
Conclusions
This study provides evidence of the large economic cost 
of malaria care in a high transmission region of Mozam-
bique, where data on the societal cost of malaria are 
scarce. The results demonstrate the substantial economic 
burden imposed by malaria among the households in 
Mopeia who already confront financial vulnerability. This 
study also shows the important financial constraint that 
malaria represents for the Mozambican health system, 
particularly in high transmission and difficult to reach 
regions. These findings provide important parameter val-
ues for the determination of cost-effectiveness of malaria 
prevention and control interventions such as IRS. More 
importantly, the results underscore the importance 
of investing in malaria prevention to reduce the high 
malaria burden and improve productivity.
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